APPROVAL HAS
BEEN EXTENDED WITH THE UNDERSTANDING THAT THE REGULATION CONTAINING
THE RECORDKEEPING REQUIREMENT WILL BE PROPOSED FOR RECISSIO
Inventory as of this Action
Requested
Previously Approved
07/31/1984
07/31/1984
03/31/1983
1,935
0
3,575
15,480
0
28,600
0
0
0
THIS REQUIRES THE REPORTING OF
INFORMATION ON EACH MANUFACTURED LOT OF BLOOD GROUPING SERUM FOR
AGENCY TESTING, EVALUATION, AND OFFICIAL RELEASE OF THE LOT PRIOR
TO DISTRIBUTION OF THE LOT BY THE MANUFACTURE
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.